Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 79.21% is in line with its 5-year average of 74.78%, near the high end of its 5-year range (63.99%–80.91%).
0.42% above its 12-month average of 78.88%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 77.05%.
GROSS MARGIN
79.21%
GROSS MARGIN AVG TTM
78.88%
GROSS MARGIN AVG 3Y
76.73%
GROSS MARGIN AVG 5Y
74.78%
GROSS MARGIN AVG 10Y
73.50%
GROSS MARGIN AVG 15Y
72.07%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.42%
CURRENT VS 3Y AVG
+3.23%
CURRENT VS 5Y AVG
+5.93%
CURRENT VS 10Y AVG
+7.78%
CURRENT VS 15Y AVG
+9.90%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.82%
median of 781 covered companies
CURRENT VS SECTOR MEDIAN
+94.05%
vs the sector median at left
Pacira BioSciences, Inc.
Market Cap
$982.98M
Gross Margin
79.21%
TTM Avg
78.88%
3Y Avg
76.73%
5Y Avg
74.78%
Market Cap
$979.98M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$980.52M
Gross Margin
97.19%
TTM Avg
61.28%
3Y Avg
80.64%
5Y Avg
87.09%
Market Cap
$976.32M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
50.00%
5Y Avg
50.00%
Market Cap
$990.75M
Gross Margin
63.74%
TTM Avg
62.39%
3Y Avg
56.59%
5Y Avg
42.69%
Market Cap
$949.00M
Gross Margin
94.73%
TTM Avg
99.96%
3Y Avg
49.98%
5Y Avg
33.32%
Market Cap
$947.49M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | $982.98M | 79.21% | 78.88% | 76.73% | 74.78% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| MeiraGTx Holdings plc (MGTX)vs › | $980.52M | 97.19% | 61.28% | 80.64% | 87.09% |
| Aktis Oncology, Inc. (AKTS)vs › | $976.32M | 100.00% | 100.00% | 50.00% | 50.00% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $990.75M | 63.74% | 62.39% | 56.59% | 42.69% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Savara Inc. (SVRA)vs › | $955.98M | 0.00% | 0.00% | 0.00% | -2255.58% |
| Kura Oncology, Inc. (KURA)vs › | $949.00M | 94.73% | 99.96% | 49.98% | 33.32% |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $947.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.03B | 11.80% | 10.80% | 10.72% | 10.72% |
Gross Margin
79.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 77.05% |
| 2026-03-31 | 79.47% |
| 2025-12-31 | 79.53% |
| 2025-09-30 | 80.91% |
| 2025-06-30 | 77.43% |
| 2025-03-31 | 79.69% |
| 2024-12-31 | 78.70% |
| 2024-09-30 | 76.95% |
| 2024-06-30 | 75.14% |
| 2024-03-31 | 71.63% |
| 2023-12-31 | 73.69% |
| 2023-09-30 | 75.75% |
| 2023-06-30 | 71.55% |
| 2023-03-31 | 69.43% |
| 2022-12-31 | 63.99% |
| 2022-09-30 | 69.74% |
| 2022-06-30 | 70.12% |
| 2022-03-31 | 77.17% |
| 2021-12-31 | 75.50% |
| 2021-09-30 | 72.87% |
| 2021-06-30 | 74.00% |
| 2021-03-31 | 73.66% |
| 2020-12-31 | 73.05% |
| 2020-09-30 | 74.47% |
| 2020-06-30 | 70.46% |
| 2020-03-31 | 71.87% |
| 2019-12-31 | 73.94% |
| 2019-09-30 | 78.69% |
| 2019-06-30 | 75.44% |
| 2019-03-31 | 70.10% |
| 2018-12-31 | 74.79% |
| 2018-09-30 | 77.15% |
| 2018-06-30 | 75.13% |
| 2018-03-31 | 69.33% |
| 2017-12-31 | 73.07% |
| 2017-09-30 | 72.93% |
| 2017-06-30 | 66.43% |
| 2017-03-31 | 64.52% |
| 2016-12-31 | 67.60% |
| 2016-09-30 | 36.87% |
| 2016-06-30 | 66.90% |
| 2016-03-31 | 69.03% |
| 2015-12-31 | 71.97% |
| 2015-09-30 | 74.44% |
| 2015-06-30 | 68.00% |
| 2015-03-31 | 69.85% |
| 2014-12-31 | 69.30% |
| 2014-09-30 | 60.82% |
| 2014-06-30 | 57.69% |
| 2014-03-31 | 50.56% |
| 2013-12-31 | 45.25% |
| 2013-09-30 | 36.41% |
| 2013-06-30 | 40.41% |
| 2013-03-31 | 1.69% |
| 2012-12-31 | 7.44% |
| 2012-09-30 | -9.44% |
| 2012-06-30 | 45.84% |
| 2012-03-31 | 16.77% |
| 2011-12-31 | -55.94% |
| 2011-09-30 | 15.14% |
| 2011-06-30 | 14.33% |
| 2011-03-31 | 5.07% |
| 2010-12-31 | 3.79% |
| 2010-09-30 | 21.16% |
| 2010-06-30 | 6.74% |
| 2010-03-31 | 21.70% |
| 2009-12-31 | 18.81% |
| 2009-09-30 | 27.69% |
